| 1028 |
Effect of Argatroban Plus Dual Antiplatelet in Branch Atherosclerosis Disease: A Randomized Clinical Trial
|
2025-06-30 |
563 |
| 1027 |
Effects of blood pressure lowering in relation to time in acute intracerebral haemorrhage: a pooled analysis of the four INTERACT trials
|
2025-06-30 |
528 |
| 1026 |
Optimal Head-of-Bed Positioning Before Thrombectomy in Stroke
|
2025-06-30 |
341 |
| 1025 |
MRI Predictors of Cognitive Function After Lacunar Infarction
|
2025-05-27 |
759 |
| 1024 |
Extended CT angiography versus standard CT angiography for the detection of cardioaortic thrombus in patients with ischaemic stroke and transient ischaemic attack (DAYLIGHT): a prospective, randomised, open-label, blinded end-point trial
|
2025-05-27 |
424 |
| 1023 |
Intravenous Tenecteplase before Thrombectomy in Stroke
|
2025-05-27 |
424 |
| 1022 |
Effects of Intensive Blood Pressure Lowering on Brain Swelling in Thrombolyzed Acute Ischemic Stroke: The ENCHANTED Results
|
2025-04-30 |
632 |
| 1021 |
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial
|
2025-04-30 |
520 |
| 1020 |
Acute Blood Pressure Lowering and Risk of Ischemic Lesions on MRI After Intracerebral Hemorrhage
|
2025-04-30 |
593 |
| 1019 |
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
|
2025-03-31 |
571 |
| 1018 |
Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status
|
2025-03-31 |
680 |
| 1017 |
Optimal Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting: A Nationwide Cohort Study
|
2025-03-31 |
738 |
| 1016 |
Early Versus Delayed Antihypertensive Treatment After Acute Ischemic Stroke by Hypertension History (CATIS-2 Trial)
|
2025-02-27 |
617 |
| 1015 |
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion (ESCAPE-MeVO Trial)
|
2025-02-27 |
634 |
| 1014 |
Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
|
2025-02-27 |
573 |
HOME
LOGIN
